The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.
This report aims to provide a comprehensive presentation of the global market for Anti-Diabetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Diabetic Drugs. This report contains market size and forecasts of Anti-Diabetic Drugs in global, including the following market information:
Global Anti-Diabetic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-Diabetic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.?
We surveyed the Anti-Diabetic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Diabetic Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-Diabetic Drugs Market Segment Percentages, by Type, 2022 (%)
Biguanides
Sulfonylureas
Meglitinides
Thiazolidinediones
Dipeptidyl Peptidase IV Inhibitors
?-Glucosidase Inhibitors
Global Anti-Diabetic Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-Diabetic Drugs Market Segment Percentages, by Application, 2022 (%)
Type I Diabetes
Type II Diabetes
Others
Global Anti-Diabetic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-Diabetic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Diabetic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-Diabetic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astra Zeneca
Boehringer Ingelheim
Eli Lilly
Johnson & Johnson
Merck
Novartis
Novo Nordisk
Sanofi
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Diabetic Drugs, market overview.
Chapter 2: Global Anti-Diabetic Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-Diabetic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Diabetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Diabetic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Diabetic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Diabetic Drugs Overall Market Size
2.1 Global Anti-Diabetic Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Diabetic Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Diabetic Drugs Players in Global Market
3.2 Top Global Anti-Diabetic Drugs Companies Ranked by Revenue
3.3 Global Anti-Diabetic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-Diabetic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-Diabetic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Diabetic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-Diabetic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Diabetic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Diabetic Drugs Market Size Markets, 2022 & 2029
4.1.2 Biguanides
4.1.3 Sulfonylureas
4.1.4 Meglitinides
4.1.5 Thiazolidinediones
4.1.6 Dipeptidyl Peptidase IV Inhibitors
4.1.7 ?-Glucosidase Inhibitors
4.2 By Type - Global Anti-Diabetic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Diabetic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Diabetic Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Diabetic Drugs Market Size, 2022 & 2029
5.1.2 Type I Diabetes
5.1.3 Type II Diabetes
5.1.4 Others
5.2 By Application - Global Anti-Diabetic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Diabetic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Diabetic Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Diabetic Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Diabetic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Diabetic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Diabetic Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-Diabetic Drugs Revenue, 2018-2029
6.3.2 US Anti-Diabetic Drugs Market Size, 2018-2029
6.3.3 Canada Anti-Diabetic Drugs Market Size, 2018-2029
6.3.4 Mexico Anti-Diabetic Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-Diabetic Drugs Revenue, 2018-2029
6.4.2 Germany Anti-Diabetic Drugs Market Size, 2018-2029
6.4.3 France Anti-Diabetic Drugs Market Size, 2018-2029
6.4.4 U.K. Anti-Diabetic Drugs Market Size, 2018-2029
6.4.5 Italy Anti-Diabetic Drugs Market Size, 2018-2029
6.4.6 Russia Anti-Diabetic Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Anti-Diabetic Drugs Market Size, 2018-2029
6.4.8 Benelux Anti-Diabetic Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-Diabetic Drugs Revenue, 2018-2029
6.5.2 China Anti-Diabetic Drugs Market Size, 2018-2029
6.5.3 Japan Anti-Diabetic Drugs Market Size, 2018-2029
6.5.4 South Korea Anti-Diabetic Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Anti-Diabetic Drugs Market Size, 2018-2029
6.5.6 India Anti-Diabetic Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-Diabetic Drugs Revenue, 2018-2029
6.6.2 Brazil Anti-Diabetic Drugs Market Size, 2018-2029
6.6.3 Argentina Anti-Diabetic Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Diabetic Drugs Revenue, 2018-2029
6.7.2 Turkey Anti-Diabetic Drugs Market Size, 2018-2029
6.7.3 Israel Anti-Diabetic Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-Diabetic Drugs Market Size, 2018-2029
6.7.5 UAE Anti-Diabetic Drugs Market Size, 2018-2029
7 Anti-Diabetic Drugs Companies Profiles
7.1 Astra Zeneca
7.1.1 Astra Zeneca Company Summary
7.1.2 Astra Zeneca Business Overview
7.1.3 Astra Zeneca Anti-Diabetic Drugs Major Product Offerings
7.1.4 Astra Zeneca Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.1.5 Astra Zeneca Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Major Product Offerings
7.2.4 Boehringer Ingelheim Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Anti-Diabetic Drugs Major Product Offerings
7.3.4 Eli Lilly Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Anti-Diabetic Drugs Major Product Offerings
7.4.4 Johnson & Johnson Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Anti-Diabetic Drugs Major Product Offerings
7.5.4 Merck Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Anti-Diabetic Drugs Major Product Offerings
7.6.4 Novartis Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Anti-Diabetic Drugs Major Product Offerings
7.7.4 Novo Nordisk Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Anti-Diabetic Drugs Major Product Offerings
7.8.4 Sanofi Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Anti-Diabetic Drugs Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-Diabetic Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-Diabetic Drugs Market Drivers in Global Market
Table 3. Anti-Diabetic Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-Diabetic Drugs in Global Market
Table 5. Top Anti-Diabetic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-Diabetic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-Diabetic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-Diabetic Drugs Product Type
Table 9. List of Global Tier 1 Anti-Diabetic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Diabetic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Diabetic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-Diabetic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-Diabetic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-Diabetic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-Diabetic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-Diabetic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-Diabetic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-Diabetic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-Diabetic Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-Diabetic Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-Diabetic Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-Diabetic Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-Diabetic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-Diabetic Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Astra Zeneca Company Summary
Table 31. Astra Zeneca Anti-Diabetic Drugs Product Offerings
Table 32. Astra Zeneca Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Astra Zeneca Key News & Latest Developments
Table 34. Boehringer Ingelheim Company Summary
Table 35. Boehringer Ingelheim Anti-Diabetic Drugs Product Offerings
Table 36. Boehringer Ingelheim Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Boehringer Ingelheim Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Anti-Diabetic Drugs Product Offerings
Table 40. Eli Lilly Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Anti-Diabetic Drugs Product Offerings
Table 44. Johnson & Johnson Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Merck Company Summary
Table 47. Merck Anti-Diabetic Drugs Product Offerings
Table 48. Merck Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Anti-Diabetic Drugs Product Offerings
Table 52. Novartis Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Novo Nordisk Company Summary
Table 55. Novo Nordisk Anti-Diabetic Drugs Product Offerings
Table 56. Novo Nordisk Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novo Nordisk Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Anti-Diabetic Drugs Product Offerings
Table 60. Sanofi Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Company Summary
Table 63. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product Offerings
Table 64. Teva Pharmaceutical Industries Anti-Diabetic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Key News & Latest Developments
List of Figures
Figure 1. Anti-Diabetic Drugs Segment by Type in 2022
Figure 2. Anti-Diabetic Drugs Segment by Application in 2022
Figure 3. Global Anti-Diabetic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Diabetic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Diabetic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Diabetic Drugs Revenue in 2022
Figure 8. By Type - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-Diabetic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-Diabetic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 16. US Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 28. China Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-Diabetic Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-Diabetic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Astra Zeneca Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boehringer Ingelheim Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novo Nordisk Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Anti-Diabetic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
